Curran, A.; Rull, A.; Navarro, J.; Vidal-González, J.; Martin-Castillo, M.; Burgos, J.; Falcó, V.; Ribera, E.; Torrella, A.; Planas, B.;
et al. Lipidomics Reveals Reduced Inflammatory Lipid Species and Storage Lipids after Switching from EFV/FTC/TDF to RPV/FTC/TDF: A Randomized Open-Label Trial. J. Clin. Med. 2020, 9, 1246.
https://doi.org/10.3390/jcm9051246
AMA Style
Curran A, Rull A, Navarro J, Vidal-González J, Martin-Castillo M, Burgos J, Falcó V, Ribera E, Torrella A, Planas B,
et al. Lipidomics Reveals Reduced Inflammatory Lipid Species and Storage Lipids after Switching from EFV/FTC/TDF to RPV/FTC/TDF: A Randomized Open-Label Trial. Journal of Clinical Medicine. 2020; 9(5):1246.
https://doi.org/10.3390/jcm9051246
Chicago/Turabian Style
Curran, Adrian, Anna Rull, Jordi Navarro, Judit Vidal-González, Mario Martin-Castillo, Joaquin Burgos, Vicenç Falcó, Esteban Ribera, Ariadna Torrella, Bibiana Planas,
and et al. 2020. "Lipidomics Reveals Reduced Inflammatory Lipid Species and Storage Lipids after Switching from EFV/FTC/TDF to RPV/FTC/TDF: A Randomized Open-Label Trial" Journal of Clinical Medicine 9, no. 5: 1246.
https://doi.org/10.3390/jcm9051246
APA Style
Curran, A., Rull, A., Navarro, J., Vidal-González, J., Martin-Castillo, M., Burgos, J., Falcó, V., Ribera, E., Torrella, A., Planas, B., Peraire, J., & Crespo, M.
(2020). Lipidomics Reveals Reduced Inflammatory Lipid Species and Storage Lipids after Switching from EFV/FTC/TDF to RPV/FTC/TDF: A Randomized Open-Label Trial. Journal of Clinical Medicine, 9(5), 1246.
https://doi.org/10.3390/jcm9051246